Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API

Ashishkumar Kyada

6 та иш

Department of Pharmacy, Faculty of Health Sciences, Marwadi University, Rajkot, Gujarat, 360003, India

  1. Exosomal microRNA as a key regulator of PI3K/AKT pathways in human tumors

    Saade Abdalkareem Jasim, Abdulrahman T. Ahmed, Aziz Kubaev +7

    Шарҳ мақолаExtracellular vesicles in diseaseMedical Oncology20240 иқтибос
    ABI

  2. Exploring the modulation of TLR4 and its associated ncRNAs in cancer immunopathogenesis, with an emphasis on the therapeutic implications and mechanisms underlying drug resistance

    Mohammad Y. Alshahrani, Enwa Felix Oghenemaro, Jasur Rizaev +7

    Шарҳ мақолаImmune Response and InflammationHuman Immunology20240 иқтибос
    ABI

  3. Mechanistic insights into ubiquinone Q10 in Parkinson’s disease: mitochondrial protection, ferroptosis inhibition, and antioxidant recycling

    Mohamed J. Saadh, Tamara Nazar Saeed, Ali Fawzi Al-Hussainy +9

    Шарҳ мақолаCoenzyme Q10 studies and effectsArchives of Physiology and Biochemistry20250 иқтибос
    ABI

  4. The effect of melatonin supplementation on lipid profile, oxidative stress, inflammatory marker, and sleep quality in patients with chronic kidney disease: a GRADE assessed meta-analysis

    Qamar Abuhassan, Zahraa Sabah Ghnim, Morug Salih Mahdi +9

    МақолаCircadian rhythm and melatoninFrontiers in Nutrition20260 иқтибос
    ABI

  5. Nanoparticle-Based PCSK9 Inhibition in Viral Infections: Evaluating Clinical Limitations and Advancing Therapeutic Strategies

    Moeen F. Dababneh, Bahjat Alhasso, Abdulkareem Shareef +10

    МақолаLipoproteins and Cardiovascular HealthJournal of Pharmaceutical Innovation20260 иқтибос
    ABI

  6. Integrin-linked kinase (ILK) in hematologic malignancies: Bridging molecular mechanisms to therapeutic innovation

    Omer Qutaiba B. Allela, Abdulkareem Shareef, Ashishkumar Kyada +9

    МақолаCell Adhesion Molecules ResearchBioimpacts20260 иқтибос
    ABI